FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022941161> ?p ?o ?g. }

• W2022941161 endingPage "198" @default.
• W2022941161 startingPage "187" @default.
• W2022941161 abstract "Multidrug resistant (MDR) cancer is difficult to treat. Chemicals that are effective MDR modulators have never exited clinical trials as FDA approved products due to side effects. It has been hypothesized that using a combination of chemotherapeutics with a mixture of MDR modulators (each with different side effects) may lead to useful treatment strategies. Because the experimental space for combination treatments can be large, this space may be impracticable to explore using animal studies. Here we describe an in vitro system based on microfabrication and cell culture that can potentially be used to explore large experimental spaces efficiently. The Microscale Cell Culture Analog (microCCA) concept mimics the body's response using interconnected compartments that represent various tissues or organs. A microCCA is based on the structure of an appropriate physiologically based pharmacokinetic (PBPK) model and emulates the body's dynamic response to exposure to various drugs and chemicals. For this problem we have chosen a microCCA with living cells representing the liver (HepG2/C3A), bone marrow (MEG-01), uterine cancer (MES-SA), and a MDR variant of uterine cancer (MES-SA/DX-5). In proof of concept experiments we found in 24 h acute exposures and 72 h treatments that the microCCA system predicts combining the chemotherapeutic, doxorubicin, with cyclosporine and nicardipine, as MDR modulators will have greater efficacy than using doxorubicin by itself or with either modulator alone. This combined strategy is selective in inhibiting MES-SA/DX-5 cell proliferation and may prove to be advantageous in vivo by specifically targeting MDR cancer with acceptable side-effects. This cell specific synergy was not observed in traditional 96-well plate assays. By combining the microCCA with a PBPK model, appropriate drug doses and area under the curve exposure for in vivo trials can be extrapolated directly from the results obtained with this device. This device and approach should be useful in screening potential drug/modulator combinations to determine candidate treatments for MDR cancer. Indeed this approach may be useful for in vitro evaluation of human response to a wide range of exposures to mixtures of chemicals or drugs." @default.
• W2022941161 created "2016-06-24" @default.
• W2022941161 creator A5008392252 @default.
• W2022941161 creator A5013234560 @default.
• W2022941161 date "2009-05-01" @default.
• W2022941161 modified "2023-10-01" @default.
• W2022941161 title "A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers" @default.
• W2022941161 cites W102593176 @default.
• W2022941161 cites W147439079 @default.
• W2022941161 cites W1574035578 @default.
• W2022941161 cites W1979779875 @default.
• W2022941161 cites W1989326344 @default.
• W2022941161 cites W2005934833 @default.
• W2022941161 cites W2008879615 @default.
• W2022941161 cites W2013612087 @default.
• W2022941161 cites W2027578741 @default.
• W2022941161 cites W2028350610 @default.
• W2022941161 cites W2029367797 @default.
• W2022941161 cites W2029717892 @default.
• W2022941161 cites W2029988210 @default.
• W2022941161 cites W2034113803 @default.
• W2022941161 cites W2039628013 @default.
• W2022941161 cites W2044200539 @default.
• W2022941161 cites W2058170382 @default.
• W2022941161 cites W2060201297 @default.
• W2022941161 cites W2075168326 @default.
• W2022941161 cites W2099191040 @default.
• W2022941161 cites W2106065228 @default.
• W2022941161 cites W2112742669 @default.
• W2022941161 cites W2129404315 @default.
• W2022941161 cites W2136746348 @default.
• W2022941161 cites W2139424714 @default.
• W2022941161 cites W2163397065 @default.
• W2022941161 cites W2247265389 @default.
• W2022941161 cites W2412056440 @default.
• W2022941161 cites W4236537241 @default.
• W2022941161 doi "https://doi.org/10.1002/bit.22219" @default.
• W2022941161 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19137589" @default.
• W2022941161 hasPublicationYear "2009" @default.
• W2022941161 type Work @default.
• W2022941161 sameAs 2022941161 @default.
• W2022941161 citedByCount "125" @default.
• W2022941161 countsByYear W20229411612012 @default.
• W2022941161 countsByYear W20229411612013 @default.
• W2022941161 countsByYear W20229411612014 @default.
• W2022941161 countsByYear W20229411612015 @default.
• W2022941161 countsByYear W20229411612016 @default.
• W2022941161 countsByYear W20229411612017 @default.
• W2022941161 countsByYear W20229411612018 @default.
• W2022941161 countsByYear W20229411612019 @default.
• W2022941161 countsByYear W20229411612020 @default.
• W2022941161 countsByYear W20229411612021 @default.
• W2022941161 countsByYear W20229411612022 @default.
• W2022941161 countsByYear W20229411612023 @default.
• W2022941161 crossrefType "journal-article" @default.
• W2022941161 hasAuthorship W2022941161A5008392252 @default.
• W2022941161 hasAuthorship W2022941161A5013234560 @default.
• W2022941161 hasConcept C112705442 @default.
• W2022941161 hasConcept C114851261 @default.
• W2022941161 hasConcept C121608353 @default.
• W2022941161 hasConcept C126322002 @default.
• W2022941161 hasConcept C133936738 @default.
• W2022941161 hasConcept C150903083 @default.
• W2022941161 hasConcept C207001950 @default.
• W2022941161 hasConcept C2776694085 @default.
• W2022941161 hasConcept C2780035454 @default.
• W2022941161 hasConcept C2781303535 @default.
• W2022941161 hasConcept C502942594 @default.
• W2022941161 hasConcept C71924100 @default.
• W2022941161 hasConcept C86803240 @default.
• W2022941161 hasConcept C89423630 @default.
• W2022941161 hasConcept C96232424 @default.
• W2022941161 hasConcept C98274493 @default.
• W2022941161 hasConceptScore W2022941161C112705442 @default.
• W2022941161 hasConceptScore W2022941161C114851261 @default.
• W2022941161 hasConceptScore W2022941161C121608353 @default.
• W2022941161 hasConceptScore W2022941161C126322002 @default.
• W2022941161 hasConceptScore W2022941161C133936738 @default.
• W2022941161 hasConceptScore W2022941161C150903083 @default.
• W2022941161 hasConceptScore W2022941161C207001950 @default.
• W2022941161 hasConceptScore W2022941161C2776694085 @default.
• W2022941161 hasConceptScore W2022941161C2780035454 @default.
• W2022941161 hasConceptScore W2022941161C2781303535 @default.
• W2022941161 hasConceptScore W2022941161C502942594 @default.
• W2022941161 hasConceptScore W2022941161C71924100 @default.
• W2022941161 hasConceptScore W2022941161C86803240 @default.
• W2022941161 hasConceptScore W2022941161C89423630 @default.
• W2022941161 hasConceptScore W2022941161C96232424 @default.
• W2022941161 hasConceptScore W2022941161C98274493 @default.
• W2022941161 hasIssue "1" @default.
• W2022941161 hasLocation W20229411611 @default.
• W2022941161 hasLocation W20229411612 @default.
• W2022941161 hasOpenAccess W2022941161 @default.
• W2022941161 hasPrimaryLocation W20229411611 @default.
• W2022941161 hasRelatedWork W2004556784 @default.
• W2022941161 hasRelatedWork W2025106411 @default.
• W2022941161 hasRelatedWork W2129571992 @default.
• W2022941161 hasRelatedWork W2326439019 @default.

• next